Quick Takeaways
- Merilee Raines has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,739,047.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Merilee Raines
- Location
- Westbrook, ME
- Summary
- The estimated net worth of Merilee Raines is at least $6,739,047 dollars as of 05 Aug 2025. Merilee Raines is the Director of WATTS WATER TECHNOLOGIES INC and owns shares of WATTS WATER TECHNOLOGIES INC (WTS) stock worth about $5.4M. Merilee Raines is the Director of BENCHMARK ELECTRONICS INC and owns shares of BENCHMARK ELECTRONICS INC (BHE) stock worth about $615.9K. Merilee Raines is the Director of TransMedics Group, Inc. and owns shares of TransMedics Group, Inc. (TMDX) stock worth about $375.2K. Merilee Raines is the Director of OCULAR THERAPEUTIX, INC and owns shares of OCULAR THERAPEUTIX, INC (OCUL) stock worth about $349.6K.
- Signature
- /s/ Seth M. Kipp, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Merilee Raines and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: WATTS WATER TECHNOLOGIES INC ($5,398,326).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Merilee Raines
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| WTS | WATTS WATER TECHNOLOGIES INC | Director | $5,398,326 | 05 Aug 2025 | ||
| BHE | BENCHMARK ELECTRONICS INC | Director | $615,898 | 12 May 2021 | ||
| TMDX | TransMedics Group, Inc. | Director | $375,173 | 22 May 2025 | ||
| OCUL | OCULAR THERAPEUTIX, INC | Director | $349,650 | 11 Jun 2025 |
Insider Transactions Reported by Merilee Raines:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.